Correlations between COPD Assessment Test and Modified British Medical Research Council Scoring and Degree of Airflow Limitation

Dian Nuryanda; Hendarsyah Suryadinata; Ambrosius Purba

doi:10.15850/amj.v4n4.1258

Correlations between COPD Assessment Test and Modified British Medical Research Council Scoring and Degree of Airflow Limitation

Dian Nuryanda, Hendarsyah Suryadinata, Ambrosius Purba

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) and Modified British Medical Research Council (MMRC) dyspnea scale are tools used to assess health status in COPD patients, while Forced Expiratory Volume in one second (FEV1) may represent the degree of airflow limitation. Assessment of COPD patients is rarely performed comprehensively. This study aimed to determine the relationships of CAT and MMRC dyspnea scale and the degree of airflow limitation in COPD patients.

Methods: The study was conducted from September until October 2014 after obtaining approval from the Hasan Sadikin General Hospital Ethics Committee. This observational analytic study was performed on 77 medical records of COPD patients at Hasan Sadikin General Hospital. Patients’ medical records included in this study were those with spirometry measurements results, CAT and MMRC dyspnea scale scoring. Data normality was analyzed using Kolmogorov-Smirnov Test. Pearson’s Correlation was used for parametric variables. Spearman’s correlation was used for non-parametric variables.

Results: Results showed Pearson’s correlation of CAT and FEV1 (p value=0.035 and r=0.240), and Spearman’s correlation of MMRC dyspnea scale and FEV1 (p value=0.198 and r=0.148).

Conclusions: CAT scoring is significantly correlated with the degree of airway limitation. MMRC dyspnea scale is not significantly correlated with the degree of airway limitation.

Keywords

Chronic Obstructive Pulmonary Disease (COPD); COPD Assessment Test (CAT), degree of airway limitation; Modified British Medical Research Council (MMRC)

Full Text:

PDF

References

Vestbo J, Hurd S, Agusti A, Jones P, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2014;187(4):347–65.

WHO. Global status report on noncommunicable diseases 2010: description of the global burden of NCDs, their risk factors and determinants. Geneva: WHO Library Cataloguing-in-Publication Data; 2011.

Jones P, Harding G, Berry P, Wiklund I, Chen W, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54.

Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129–35.

Pitta F, Takaki MY, Oliveira NHD, Sant’Anna TJP, Fontana AD, Kovelis D, et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir Med. 2008;102(8):1203–7.

Garrido PC, Diez JDM, Gutierrez JR, Centeno AM, Vazquez GE, Angel GDM, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4:31:1–9.

Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–68.

Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33–7.

Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med. 2008;102(3):399–406.

Wise RA. Chronic obstructive pulmonary disease: clinical course and management. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, editors. Fishman’s pulmonary diseases and disorders. 4th ed. New York: Mc Graw Hill; 2008. p. 729–46.

DOI: https://doi.org/10.15850/amj.v4n4.1258